MedTrace Logo

Assessing Cosopt Switch Patients

NCT00273442 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-11-19

No results posted yet for this study

Summary

To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherapy.

Conditions

Interventions

DRUG

timolol maleate

DRUG

dorzolamide/timolol maleate fixed combination

Sponsors & Collaborators

  • Pharmaceutical Research Network

    lead OTHER

Principal Investigators

  • William C. Stewart, MD · Pharmaceutical Research Network, LLC

  • Mark J. Weiss, MD

  • Douglas G. Day, MD · Omni Eye Services

  • Sriram Sonty, MD, FACS · Midwest Eye Center

  • J. Charles Henry, MD · Little Rock Eye Clinic

  • Elizabeth D. Sharpe, MD · Glaucoma Consultants & Center for Eye Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273442 on ClinicalTrials.gov